company background image
ERF logo

Eurofins Scientific ENXTPA:ERF 株式レポート

最終価格

€57.90

時価総額

€11.1b

7D

10.3%

1Y

8.2%

更新

29 Sep, 2024

データ

会社財務 +

Eurofins Scientific SE

ENXTPA:ERF 株式レポート

時価総額:€11.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

ERF 株式概要

ユーロフィンズ・サイエンティフィックSEは、その子会社とともに、世界中で様々な分析試験やラボサービスを提供している。

ERF ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長3/6
過去の実績1/6
財務の健全性4/6
配当金0/6

Eurofins Scientific SE 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめEurofins Scientific
過去の株価
現在の株価€57.90
52週高値€62.10
52週安値€39.47
ベータ0.68
11ヶ月の変化12.12%
3ヶ月変化26.01%
1年変化8.22%
33年間の変化-45.32%
5年間の変化30.52%
IPOからの変化24,230.80%

最新ニュース

Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Aug 17
Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 27
Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Aug 17
Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 27
Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively

May 10
These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively

We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Apr 19
We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings

Apr 18
Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Nov 10
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

Oct 23
Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Aug 07
We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

Jul 20
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

May 03
We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Apr 11
Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Jan 05
Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

Dec 14
Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Oct 03
An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Sep 06
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Jun 25
Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Jun 16
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Jun 01
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

Apr 12
Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Feb 25
These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Nov 28
Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Nov 14
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Sep 30
Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

Aug 29
Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Aug 15
We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Jun 24
Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

May 25
Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Mar 31
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Mar 17
Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Mar 03
Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Mar 03
Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Feb 15
Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

Dec 28
Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?

Dec 14
How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?

Eurofins Scientific (EPA:ERF) Is Growing Earnings But Are They A Good Guide?

Nov 30
Eurofins Scientific (EPA:ERF) Is Growing Earnings But Are They A Good Guide?

株主還元

ERFFR Life SciencesFR 市場
7D10.3%4.5%5.5%
1Y8.2%3.4%5.9%

業界別リターン: ERF過去 1 年間で-1.2 % の収益を上げたFrench Life Sciences業界を上回りました。

リターン対市場: ERF過去 1 年間で2.7 % の収益を上げたFrench市場を上回りました。

価格変動

Is ERF's price volatile compared to industry and market?
ERF volatility
ERF Average Weekly Movement4.0%
Life Sciences Industry Average Movement5.9%
Market Average Movement4.7%
10% most volatile stocks in FR Market9.5%
10% least volatile stocks in FR Market2.1%

安定した株価: ERF過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: ERFの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
198761,798Gilles Martinwww.eurofins.com

ユーロフィンズ・サイエンティフィックSEは、その子会社とともに、世界中で様々な分析試験やラボサービスを提供している。同社は、様々な製品の安全性、同一性、組成、真正性、原産地、トレーサビリティ、純度を評価するための様々な分析手法や試験のポートフォリオを提供している。生物学的評価、消費者・人体・環境安全性、製品化学、規制コンサルタント、種子サービスなどのアグロサイエンス、農業試験、食品、消費者製品、ヘルスケア、化粧品、食品サプリメントの製品検査、監査、認証、トレーニング、コンサルティングなどのアシュアランス、バイオファーマ、臨床診断などのサービスを提供している。さらに、持続可能性、専門家サービスと規制、消費者調査と官能評価、監査、試験、認証と承認、検査、様々な業界向けのトレーニングコースを含む消費者製品検査、化粧品とパーソナルケア、水、空気、土壌、廃棄物、その他の製品検査を含む環境検査、アレルゲン、遺伝子組み換え、穀物、食肉、ナノ材料、農薬、残留DNA検査を含む食品と飼料検査を提供している。さらに、監査と認証、トレーニングとコンサルティング、食品照射と表示、重金属、炭水化物、放射能、栄養分析、微生物検査、残留性有機汚染物質、動物用医薬品の残留、ダイオキシン類と有機汚染物質、農薬、マイコトキシン、ビタミンの検査、遺伝子組み換えの分析も提供している。さらに、法医学、ゲノム、海事、材料とエンジニアリング、REACH、その他のサービスも提供している。同社は1987年に設立され、ルクセンブルクのルクセンブルク市に本社を置いている。

Eurofins Scientific SE 基礎のまとめ

Eurofins Scientific の収益と売上を時価総額と比較するとどうか。
ERF 基礎統計学
時価総額€11.08b
収益(TTM)€325.90m
売上高(TTM)€6.72b

34.0x

PER(株価収益率

1.6x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
ERF 損益計算書(TTM)
収益€6.72b
売上原価€5.23b
売上総利益€1.49b
その他の費用€1.17b
収益€325.90m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)1.70
グロス・マージン22.19%
純利益率4.85%
有利子負債/自己資本比率55.3%

ERF の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.9%

現在の配当利回り

30%

配当性向